Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis

Patients with chronic liver disease (CLD) and cirrhosis are at high risk for hepatocellular carcinoma (HCC). Current diagnostic tools for HCC detection include imaging techniques and serum biomarkers such as α-fetoprotein (AFP). Yet, these methods are limited in sensitivity and specificity to accura...

Descripción completa

Detalles Bibliográficos
Autores principales: Dengler, Mirko, Staufer, Katharina, Huber, Heidemarie, Stauber, Rudolf, Bantel, Heike, Weiss, Karl Heinz, Starlinger, Patrick, Pock, Hannelore, Klöters-Plachky, Petra, Gotthardt, Daniel N., Rauch, Peter, Lackner, Carolin, Stift, Judith, Brostjan, Christine, Gruenberger, Thomas, Kumada, Takashi, Toyoda, Hidenori, Tada, Toshifumi, Weiss, Thomas S., Trauner, Michael, Mikulits, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542263/
https://www.ncbi.nlm.nih.gov/pubmed/28526812
http://dx.doi.org/10.18632/oncotarget.17598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542263/
https://www.ncbi.nlm.nih.gov/pubmed/28526812
http://dx.doi.org/10.18632/oncotarget.17598

Ejemplares similares